Clinical Trial Update: Gene Therapy for Transfusion Dependent Beta-thalassemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for a gene therapy targeting transfusion-dependent beta-thalassemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Beta-Thalassemia | Phase 1, Phase 2 | Status: UNKNOWN